Bulagsac, Dulcesima B.

HRN: 05-10-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/23/2023
04/29/2023
IV
1.5g
Q6H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action 
04/24/2023
AZITHROMYCIN 500MG TABLET (TAB)
04/24/2023
04/28/2023
PO
500mgtab
OD
Pneumonia
Waiting Final Action 
04/24/2023
MUPIROCIN 2%, 15G (TUBE)
04/24/2023
05/01/2023
TOPICAL
BID
BID
T/C Contact Dermatitis With Bacterial Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: